Nalitt Cancer Institute at Staten Island University Hospital — Staten Island, New York

Nalitt Cancer Institute at Staten Island University Hospital is a clinical research site located in Staten Island, New York, United States 10305.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Nalitt Cancer Institute at Staten Island University Hospital has participated in 16 clinical trials.

Therapeutic areas: Breast Cancer, Colorectal Cancer, Metastatic Cancer.

Sponsors: NSABP Foundation Inc, Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nalitt Cancer Institute at Staten Island University Hospital?

Nalitt Cancer Institute at Staten Island University Hospital has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nalitt Cancer Institute at Staten Island University Hospital conducted?

Nalitt Cancer Institute at Staten Island University Hospital has 16 clinical trials on record. Their work covers Breast Cancer, Colorectal Cancer, Metastatic Cancer.

Is Nalitt Cancer Institute at Staten Island University Hospital accredited by Crixeo Health?

Nalitt Cancer Institute at Staten Island University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nalitt Cancer Institute at Staten Island University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.